Recent studies have suggested that valsartan increases glucose-stimulated insulin secretion (GSIS) and insulin sensitivity in normotensive subjects with impaired glucose tolerance (IGT) [18]. The gene discussed is INS; the disease is Impaired glucose tolerance.